Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 32)
25 February 2026
UBE Invests in South Korea's CheomdanLab
CheomdanLab develops silicon nitride tech for recycling silicon waste, aiding sustainable supply chains. UBE supports their mass production and commercialization efforts.
25 February 2026
Clariant Gains EU Approval for Rice Bran Wax in Food-Contact Plastics
EU approval allows rice bran wax additives in PET, PLA, and PVC for food-contact, offering a sustainable alternative to montan wax with lower carbon footprint and supply chain benefits.
24 February 2026
Honeywell and Verso Energy Partner to Boost eSAF Production
Verso Energy will use Honeywell's eFining technology to produce eSAF, reducing GHG emissions by 88% and meeting EU's 2050 fuel requirements.
24 February 2026
Toray Unveils Spherical PA12 Particles for Enhanced 3D Printing
New spherical PA12 particles improve 3D-printed parts' surface smoothness and impact strength, enhancing quality and expanding applications in prototypes and functional parts.
24 February 2026
QEMETICA and Łukasiewicz Partner for Chemical Innovation
The partnership focuses on developing advanced materials, energy-efficient solutions, and dual-use technologies for industrial transformation and sustainability.
24 February 2026
Johnson & Johnson Seeks FDA Approval for IMAAVY® to Treat wAIHA
IMAAVY® targets wAIHA by blocking FcRn, reducing IgG. Phase 2/3 study shows improved hemoglobin and fatigue.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
24 February 2026
Aurubis Lünen Launches High-Purity Oxygen Plant in North Rhine-Westphalia
The new air separation unit boosts production efficiency, supply security, and reduces CO2 emissions by 8,500 t annually, enhancing the site's role in the circular economy.
24 February 2026
Novo Nordisk's UBT251 Achieves 19.7% Weight Loss in Phase 2 China Trial
UBT251, a triple agonist, showed significant weight loss and improved health markers in a Chinese phase 2 trial, with a safe and well-tolerated profile.
24 February 2026
Brenntag Partners with Nanum for Nanomaterials Distribution
The agreement enhances Brenntag's specialty offerings in Brazil, integrating advanced nanotechnology for improved solutions in coatings, polymers, energy, and water treatment sectors.
24 February 2026
Nobian and Macquarie Sell HyCC to Power2X
Power2X will enhance HyCC's green hydrogen projects, aligning with its decarbonization strategy. Nobian continues its focus on chlorine electrolysis and green hydrogen in Europe.
23 February 2026
thyssenkrupp Steel to Supply CO₂-Reduced Steel for BMW iX3 Production
bluemint® recycled steel, with high recycled content and CO₂ savings, will be used in BMW iX3's outer panels and battery housing, meeting quality and safety standards without process changes.
23 February 2026
Honeywell Amends Agreement to Acquire Johnson Matthey's Catalyst Technologies
The acquisition price is adjusted to £1.325 billion, with completion expected by August 2026, pending regulatory approvals. The deal aims to enhance growth and synergies in process technologies.
23 February 2026
Holcim 2025: Double-Digit EBIT Growth, 18.3% Margin
Net sales rose 3%, EBIT margin expanded by 80bps. EPS up 5%, free cash flow at CHF 2.15B. 21 transactions completed, guiding for 2026 growth and increased recycling.
23 February 2026
Toray Develops Bio-Based Polyamide 4 for Cosmetics Market
Toray's new bio-based polyamide 4 offers biodegradability, reducing microplastic pollution in cosmetics, with potential applications in semiconductors and pharmaceuticals.
23 February 2026
thyssenkrupp Steel Supplies CO₂-Reduced Steel for BMW iX3 Production
bluemint® Steel, a CO₂-reduced product, will be used in BMW iX3's outer panels and battery housing, enhancing sustainability and meeting high quality standards.
23 February 2026
Valio's Recycled Packaging Initiative
By 2030, 80% of Valio's packaging will use renewable or recycled materials, with clear consumer labeling to enhance understanding and trust in circular packaging.
23 February 2026
Novo Nordisk: CagriSema Shows 23% Weight Loss in Trial, Misses Primary Endpoint
CagriSema achieved 23% weight loss in 84 weeks but didn't match tirzepatide. Further trials will explore higher doses. Safe profile with mild gastrointestinal effects.
23 February 2026
AMAG Secures €75M EIB Loan for R&D Innovation
EIB's first TechEU loan in Austria supports digital and green advancements, boosting Europe's industrial base and securing critical raw materials.
21 February 2026
Johnson & Johnson's TREMFYA® Shows Sustained Remission in Ulcerative Colitis Over 3 Years
TREMFYA® maintains clinical, endoscopic, and histologic outcomes in ulcerative colitis through 140 weeks, with high patient retention and no new safety concerns.
20 February 2026
Chugai Launches Japan's First Regenerative Treatment for Duchenne Muscular Dystrophy
ELEVIDYS, a one-time therapy for DMD, targets ambulatory patients aged 3-7. Safety measures and post-marketing studies are in place following reports of liver failure cases.
20 February 2026
Eni Launches Ndungu Full-Field Offshore Angola
Ndungu full-field starts production offshore Angola, boosting output to 60,000 barrels/day. Part of Agogo IWH, it enhances Angola's oil capacity and aligns with low-carbon goals.
20 February 2026
EU Allocates €225M for Advanced Flu Vaccine Development
The EU funds next-gen flu vaccines to enhance protection, speed up development, and improve pandemic readiness through pre-commercial procurement.
20 February 2026
Roche's Giredestrant NDA Accepted by FDA for Advanced Breast Cancer
FDA accepts giredestrant NDA based on phase III data showing reduced disease progression risk in ER-positive breast cancer. Decision expected by December 18, 2026.
19 February 2026
Statkraft transfers Silva Green Fuel technology to Silva Biofuel
Demo facility and HTL expertise transferred to a new company run by former employees; CEO named and investors invited to scale toward commercial plants; deal pending regulatory approval.
19 February 2026
Altris awarded EIC funding to industrialize sodium‑ion batteries
Secures €2.5M grant plus up to €10M equity to scale Prussian‑White sodium‑ion cathode production, expand European manufacturing, validate with industrial partners and accelerate commercial rollout.
19 February 2026
LanzaJet Secures $47M in New Funding, Valued at $650M
Existing investors boost LanzaJet's ATJ technology growth, supporting commercial deployment and securing feedstock supply through a multi-year tolling structure.
19 February 2026
Zenyaku's Rituxan Approved for Autoimmune Hemolytic Anemia Treatment
Rituxan gains approval for treating autoimmune hemolytic anemia, targeting B cells to reduce autoantibodies. Effective for warm AIHA, CAD, and PCH, offering an alternative to steroids.
19 February 2026
Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition
Commercialized in 1983, thin-film Hall elements revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
19 February 2026
Velocys Achieves 30% Cost Reduction in microFTL™ Technology Deployment
Standardisation and delivery efficiencies enhance capital efficiency for Altalto and NovaSAF 1 projects, advancing them toward final engineering and investment decisions.
19 February 2026
Lilly's Omvoh Maintains Steroid-Free Remission in Crohn's Patients for Three Years
Omvoh shows durable efficacy in Crohn's and UC, with low surgery rates and sustained symptom relief over three years, maintaining steroid-free remission in over 90% of patients.
← Previous
Next →
